| Year |
Citation |
Score |
| 2015 |
Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Weiner W, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736 |
0.49 |
|
| 2012 |
Morrow C, Smentkowski K, Schwartz S, Gruber-Baldini A, Anderson K, Weiner W, Reich S, Shulman L. Does Spouse Participation Influence Quality of Life Reporting in Patients with Parkinson's Disease? (P06.063) Neurology. 78: P06.063-P06.063. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.063 |
0.368 |
|
| 2012 |
Shulman L, Gruber-Baldini A, Anderson K, Figari-Jordan R, Fishman P, Reich S, Weiner W. Is Quality of Life Affected Equally by Decline and Improvement in Parkinson Disease Severity? (P06.062) Neurology. 78: P06.062-P06.062. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.062 |
0.34 |
|
| 2011 |
Robottom BJ, Factor SA, Weiner WJ. Movement disorders emergencies Part 2: hyperkinetic disorders. Archives of Neurology. 68: 719-24. PMID 21670395 DOI: 10.1001/archneurol.2011.117 |
0.418 |
|
| 2011 |
Robottom BJ, Weiner WJ, Factor SA. Movement disorders emergencies. Part 1: Hypokinetic disorders. Archives of Neurology. 68: 567-72. PMID 21555633 DOI: 10.1001/archneurol.2011.84 |
0.475 |
|
| 2010 |
Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 75: 2021-7. PMID 21115958 DOI: 10.1212/WNL.0b013e3181ff96dd |
0.433 |
|
| 2010 |
Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 74: 924-31. PMID 20231670 DOI: 10.1212/Wnl.0B013E3181D55F24 |
0.407 |
|
| 2010 |
Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1082-6. PMID 20131372 DOI: 10.1002/mds.22997 |
0.313 |
|
| 2010 |
Robottom BJ, Shulman LM, Anderson KE, Weiner WJ. Metoclopramide-induced encephalopathy in Parkinson disease. Southern Medical Journal. 103: 178-80. PMID 20065895 DOI: 10.1097/SMJ.0b013e3181ca9b3f |
0.332 |
|
| 2010 |
Gruber-Baldini A, Anderson K, Weiner W, Fishman P, Reich S, Shulman L. 145 THE RELATIONSHIP BETWEEN GAIT IMPAIRMENT AND SELF-EFFICACY IN PARKINSON'S DISEASE Parkinsonism & Related Disorders. 16: S42. DOI: 10.1016/S1353-8020(10)70146-2 |
0.379 |
|
| 2009 |
Robottom BJ, Weiner WJ, Asmus F, Huber H, Gasser T, Schöls L. Kick and rush: paradoxical kinesia in Parkinson disease. Neurology. 73: 328; author reply 32. PMID 19636057 DOI: 10.1212/WNL.0b013e3181ab6cae |
0.321 |
|
| 2009 |
Robottom BJ, Weiner WJ. Dementia in Parkinson's disease. International Review of Neurobiology. 84: 229-44. PMID 19501721 DOI: 10.1016/S0074-7742(09)00412-7 |
0.317 |
|
| 2009 |
Weiner W, Ahlskog E, Factor S, Suchowersky O, Reich S. Initiating therapy in Parkinson's disease Annals of Neurology. 65: 480-481. PMID 19399873 DOI: 10.1002/Ana.21667 |
0.546 |
|
| 2009 |
Robottom BJ, Weiner WJ. Parkinson's disease dementia Current Psychiatry Reviews. 5: 218-225. DOI: 10.2174/157340009788971128 |
0.305 |
|
| 2009 |
Robottom B, Anderson K, Fishman P, Eisenberg H, Powell S, Reich S, Weiner W, Shulman L. P2.050 Do pre-existing psychiatric disorders affect quality of life following deep brain stimulation for Parkinson's disease? Parkinsonism & Related Disorders. 15: S101-S102. DOI: 10.1016/S1353-8020(09)70401-8 |
0.347 |
|
| 2008 |
Weiner WJ. Early diagnosis of Parkinson's disease and initiation of treatment. Reviews in Neurological Diseases. 5: 46-53; quiz 54-5. PMID 18660736 |
0.352 |
|
| 2008 |
Weiner WJ. There is no Parkinson disease. Archives of Neurology. 65: 705-8. PMID 18541790 DOI: 10.1001/archneur.65.6.705 |
0.336 |
|
| 2008 |
Shulman L, Anderson K, Gruber-Baldini A, Reich S, Fishman P, Weiner W. P2.048 The impact of gait and mental function on disability in Parkinson's disease Parkinsonism & Related Disorders. 14: S55-S56. DOI: 10.1016/S1353-8020(08)70278-5 |
0.373 |
|
| 2008 |
Factor SA, Lang AE, Weiner WJ. Preface Drug Induced Movement Disorders: Second Edition. xiii-xiv. DOI: 10.1002/9780470753217 |
0.357 |
|
| 2008 |
Weiner WJ. Early diagnosis of Parkinson's disease and initiation of treatment (Reviews in Neurological Diseases 5, 2, (51)) Reviews in Neurological Diseases. 5. |
0.315 |
|
| 2007 |
Esper CD, Weiner WJ, Factor SA. Progressive supranuclear palsy. Reviews in Neurological Diseases. 4: 209-16. PMID 18195676 |
0.496 |
|
| 2007 |
Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Appendix D: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 177-189. |
0.491 |
|
| 2006 |
Weiner WJ. Advances in the diagnosis, treatment, and understanding of Parkinson's disease and parkinsonism. Reviews in Neurological Diseases. 3: 191-4. PMID 17224903 |
0.367 |
|
| 2006 |
Weiner WJ. Motor fluctuations in Parkinson's disease. Reviews in Neurological Diseases. 3: 101-8. PMID 17047575 |
0.307 |
|
| 2006 |
Katzen HL, Levin BE, Weiner W. Side and type of motor symptom influence cognition in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1947-53. PMID 16991155 DOI: 10.1002/Mds.21105 |
0.306 |
|
| 2006 |
Salter BC, Anderson KE, Weiner WJ. Psychosis in Parkinson's disease: case studies. Neurologic Clinics. 24: 363-9. PMID 16684637 DOI: 10.1016/j.ncl.2006.01.003 |
0.318 |
|
| 2006 |
Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 983-95. PMID 16606909 DOI: 10.1212/01.wnl.0000215250.82576.87 |
0.481 |
|
| 2006 |
Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 976-82. PMID 16606908 DOI: 10.1212/01.Wnl.0000206363.57955.1B |
0.423 |
|
| 2006 |
Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 968-75. PMID 16606907 DOI: 10.1212/01.Wnl.0000215437.80053.D0 |
0.43 |
|
| 2005 |
Weiner WJ. A differential diagnosis of Parkinsonism. Reviews in Neurological Diseases. 2: 124-31. PMID 16400311 |
0.317 |
|
| 2005 |
Weiner WJ. Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy. Reviews in Neurological Diseases. 2: 20-2. PMID 16400299 |
0.335 |
|
| 2005 |
Bhat V, Weiner WJ. Parkinson's disease. Diagnosis and the initiation of therapy. Minerva Medica. 96: 145-54. PMID 16175158 |
0.356 |
|
| 2005 |
Skidmore F, Mikolenko I, Weiss H, Weiner W. Camptocormia in a patient with multiple system atrophy Movement Disorders. 20: 1063-1064. PMID 15986475 DOI: 10.1002/mds.20521 |
0.301 |
|
| 2004 |
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/Archneur.61.7.1044 |
0.55 |
|
| 2002 |
Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, Konefal J. Acupuncture therapy for the symptoms of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 799-802. PMID 12210879 DOI: 10.1002/mds.10134 |
0.306 |
|
| 2002 |
Marek K, Seibyl J, Shoulson I, Holloway R, Kieburtz K, McDermott M, Kamp C, Shinaman A, Fahn S, Lang A, Weiner W, Welsh M. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression Journal of the American Medical Association. 287: 1653-1661. PMID 11926889 |
0.307 |
|
| 2002 |
Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 58: 11-7. PMID 11781398 DOI: 10.1212/Wnl.58.1.11 |
0.388 |
|
| 2002 |
Hernandez-Reif M, Field T, Largie S, Cullen C, Beutler J, Sanders C, Weiner W, Rodriguez-Bateman D, Zelaya L, Schanber S, Kuhn C. Parkinson's disease symptoms are differentially affected by massage therapy vs. progressive muscle relaxation: A pilot study Journal of Bodywork and Movement Therapies. 6: 177-182. DOI: 10.1054/Jbmt.2002.0282 |
0.36 |
|
| 2001 |
Rabinstein A, Shulman LM, Weiner WJ. Modafinil for the treatment of excessive daytime sleepiness in Parkinson's disease: a case report. Parkinsonism & Related Disorders. 7: 287-288. PMID 11344011 DOI: 10.1016/S1353-8020(00)00035-3 |
0.437 |
|
| 2001 |
Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman PM, Beck B, Paume D, Doyle C. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. Parkinsonism & Related Disorders. 7: 115-120. PMID 11248592 DOI: 10.1016/S1353-8020(00)00031-6 |
0.598 |
|
| 2000 |
Holloway R, Shoulson I, Kieburtz K, McDermott M, Tariot P, Kamp C, Day D, Shinaman A, Fahn S, Lang A, Marek K, Seibyl J, Weiner W, Welsh M, Pahwa R, et al. Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial Journal of the American Medical Association. 284: 1931-1938. PMID 11035889 DOI: 10.1001/jama.284.15.1931 |
0.327 |
|
| 2000 |
Weiner WJ, Factor SA. Ropinirole as compared with levodopa in Parkinson's disease. The New England Journal of Medicine. 343: 885. PMID 11001687 |
0.566 |
|
| 2000 |
Hiner BC, Earnhart M, Yamamoto T, Frucht S, Weiner WJ, Factor SA, Rascol O. Ropinirole as compared with levodopa in Parkinson's disease [1] (multiple letters) New England Journal of Medicine. 343: 884-885. PMID 11001685 DOI: 10.1056/NEJM200009213431211 |
0.564 |
|
| 2000 |
Shulman LM, Minagar A, Rabinstein A, Weiner WJ. The use of dopamine agonists in very elderly patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 664-8. PMID 10928576 DOI: 10.1002/1531-8257(200007)15:4<664::Aid-Mds1010>3.0.Co;2-D |
0.376 |
|
| 2000 |
Quinn N, Minagar A, Shulman LM, Weiner WJ. Transderm-induced psychosis in Parkinson's disease [1] (multiple letters) Neurology. 54: 1877. PMID 10802809 |
0.332 |
|
| 2000 |
Weiner WJ, Minagar A, Shulman LM. Quetiapine for l-dopa-induced psychosis in PD. Neurology. 54: 1538. PMID 10751276 DOI: 10.1212/Wnl.54.7.1538 |
0.401 |
|
| 2000 |
Shulman LM, Minagar A, Weiner WJ. The effect of pregnancy in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 132-5. PMID 10634252 DOI: 10.1002/1531-8257(200001)15:1<132::Aid-Mds1020>3.0.Co;2-C |
0.354 |
|
| 2000 |
Rabinstein A, Weiner WJ. Levodopa or dopamine agonists in the early treatment of Parkinson's disease Focus On Parkinson's Disease. 12: 63-66. |
0.303 |
|
| 1999 |
Shulman LM, Minagar A, Sharma K, Weiner WJ. Amantadine-induced peripheral neuropathy. Neurology. 53: 1862-5. PMID 10563642 DOI: 10.1212/Wnl.53.8.1862 |
0.325 |
|
| 1999 |
Weiner WJ. The initial treatment of Parkinson's disease should begin with levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 716-24. PMID 10495031 DOI: 10.1002/1531-8257(199909)14:5<716::Aid-Mds1002>3.0.Co;2-Q |
0.489 |
|
| 1999 |
Minagar A, Shulman LM, Weiner WJ. Transderm-induced psychosis in Parkinson's disease. Neurology. 53: 433-4. PMID 10430448 |
0.334 |
|
| 1999 |
Weiner WJ, Minagar A, Shulman LM. Pramipexole in progressive supranuclear palsy. Neurology. 52: 873-4. PMID 10078747 DOI: 10.1212/Wnl.52.4.873 |
0.42 |
|
| 1999 |
Shulman LM, Minagar A, Weiner WJ. Perdiem causing esophageal obstruction in Parkinson's disease. Neurology. 52: 670-1. PMID 10025817 |
0.324 |
|
| 1998 |
Factor SA, Weiner WJ. 'Sleep benefit' in Parkinson's disease. Neurology. 50: 1514-5. PMID 9596032 |
0.482 |
|
| 1998 |
Weiner WJ. Pallidotomy in advanced Parkinson's disease. The New England Journal of Medicine. 338: 263. PMID 9441240 |
0.339 |
|
| 1998 |
Ryan L, Weiner WJ, Lang AE, Lozano AM. Pallidotomy in advanced Parkinson's disease [2] (multiple letters) New England Journal of Medicine. 338: 262-263. PMID 9441239 DOI: 10.1056/NEJM199801223380413 |
0.336 |
|
| 1998 |
Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, ... ... Weiner WJ, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/Mds.870130522 |
0.537 |
|
| 1997 |
Hauser RA, Zesiewicz TA, Factor SA, Guttman M, Weiner WJ. Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness. Parkinsonism & Related Disorders. 3: 1-6. PMID 18591048 DOI: 10.1016/S1353-8020(96)00042-9 |
0.528 |
|
| 1996 |
Shulman LM, Singer C, Bean JA, Weiner WJ. Internal tremor in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 3-7. PMID 8771060 DOI: 10.1002/mds.870110103 |
0.321 |
|
| 1996 |
Fahn S, Brin MF, Dwork AJ, Weiner WJ, Goetz CG, Rajput AH. Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 298-310. PMID 8723148 DOI: 10.1002/Mds.870110314 |
0.373 |
|
| 1996 |
Weiner WJ, Singer C, Shulman LM. Parkinsonism and Parkinson's disease. The New England Journal of Medicine. 334: 1611. PMID 8628354 DOI: 10.1056/NEJM199606133342418 |
0.356 |
|
| 1996 |
Shulman LM, Singer C, Levin B, Weiner WJ. Diagnostic testing for dementia in patients with Parkinson's Disease Journal of the American Geriatrics Society. 44: 214-215. PMID 8576519 DOI: 10.1111/J.1532-5415.1996.Tb02448.X |
0.402 |
|
| 1995 |
Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. Journal of Neural Transmission. Supplementum. 45: 225-30. PMID 8748629 |
0.577 |
|
| 1994 |
Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor Movement Disorders. 9: 193-196. PMID 8196682 DOI: 10.1002/Mds.870090212 |
0.313 |
|
| 1994 |
Goldenberg JN, Brown SB, Weiner WJ. Coprolalia in younger patients with Gilles de la Tourette syndrome Movement Disorders. 9: 622-625. PMID 7845402 DOI: 10.1002/Mds.870090607 |
0.305 |
|
| 1993 |
Weiner WJ, Singer C, Sanchez-Ramos JR, Goldenberg JN. Levodopa, melanoma, and Parkinson's disease Neurology. 43: 674-677. PMID 8469320 DOI: 10.1212/Wnl.43.4.674 |
0.411 |
|
| 1993 |
Weiner WJ, Factor SA, Sanchez-Ramos JR, Singer C, Sheldon C, Cornelius L, Ingenito A. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease. Neurology. 43: 21-7. PMID 8423888 DOI: 10.1212/Wnl.43.1_Part_1.21 |
0.591 |
|
| 1993 |
Factor SA, Weiner WJ. Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 257-62. PMID 8341289 DOI: 10.1002/Mds.870080302 |
0.597 |
|
| 1993 |
Tomer R, Levin BE, Weiner WJ. Side of onset of motor symptoms influences cognition in Parkinson's disease. Annals of Neurology. 34: 579-84. PMID 8215246 DOI: 10.1002/Ana.410340412 |
0.379 |
|
| 1993 |
Weiner WJ. Parkinson's disease and related syndromes Medical Section Proceedings : the . Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. 195-203. PMID 8078870 |
0.306 |
|
| 1993 |
Factor SA, Weiner WJ. Combination therapy for PD Neurology. 43: 2726-2726. DOI: 10.1212/WNL.43.12.2726 |
0.474 |
|
| 1992 |
Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson's disease European Neurology. 32: 134-140. PMID 1592069 DOI: 10.1159/000116810 |
0.403 |
|
| 1991 |
Levin BE, Llabre MM, Reisman S, Weiner WJ, Sanchez-Ramos J, Singer C, Brown MC. Visuospatial impairment in Parkinson’s disease Neurology. 41: 365-369. PMID 2006002 DOI: 10.1212/Wnl.41.3.365 |
0.437 |
|
| 1991 |
Factor SA, Weiner WJ. Prior history of head trauma in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 225-9. PMID 1922127 DOI: 10.1002/Mds.870060306 |
0.558 |
|
| 1991 |
Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice Experimental Neurology. 114: 73-81. PMID 1915737 DOI: 10.1016/0014-4886(91)90086-R |
0.315 |
|
| 1991 |
Levin BE, Llabre MM, Reisman S, Weiner WJ, Brown MC. A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease Journal of Neuropsychiatry and Clinical Neurosciences. 3: 412-416. PMID 1821262 DOI: 10.1176/Jnp.3.4.412 |
0.335 |
|
| 1991 |
Singer C, Weiner WJ, Sanchez-Ramos J, Ackerman M. Sexual function in patients with Parkinson's disease [13] Journal of Neurology Neurosurgery and Psychiatry. 54: 942. PMID 1744663 DOI: 10.1136/Jnnp.54.10.942 |
0.374 |
|
| 1990 |
Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 280-5. PMID 2259351 DOI: 10.1002/Mds.870050404 |
0.562 |
|
| 1990 |
Factor SA, Sanchez-Ramos JR, Weiner WJ. Vitamin E therapy in Parkinson's disease. Advances in Neurology. 53: 457-61. PMID 2239484 |
0.504 |
|
| 1990 |
Singer C, Sanchez-Ramos J, Weiner WJ. Levodopa-responsive parkinsonism in a patient with down’s syndrome1 European Neurology. 30: 247-248. PMID 2148520 DOI: 10.1159/000117355 |
0.414 |
|
| 1989 |
Levin BE, Llabre MM, Weiner WJ. Cognitive impairments associated with early parkinson’s disease Neurology. 39: 557-561. PMID 2927680 DOI: 10.1212/Wnl.39.4.557 |
0.369 |
|
| 1989 |
Sanchez-Ramos JR, Factor SA, Weiner WJ, Marquez J. Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 266-73. PMID 2779596 DOI: 10.1002/Mds.870040308 |
0.477 |
|
| 1989 |
Factor SA, Weiner WJ, Hefti F. Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease. Annals of Neurology. 26: 286-8. PMID 2774516 DOI: 10.1002/Ana.410260219 |
0.529 |
|
| 1989 |
Singer C, Weiner WJ. Could Parkinson's disease follow intra-uterine influenza? A speculative hypothesis Journal of Neurology, Neurosurgery and Psychiatry. 52: 931. PMID 2769296 DOI: 10.1136/Jnnp.52.7.931 |
0.393 |
|
| 1989 |
Jiao SS, Ding yj, Zhang wC, Cao JK, Zhang GF, Zhang ZM, Ding MC, Zhang Z, Meng JM, Tanner CM, Watts RL, Bakay RAE, Petruk KC, Jankovic J, Weiner WJ, et al. Adrenal Medullary Autografts in Patients with Parkinson's Disease The New England Journal of Medicine. 321: 324-327. PMID 2747774 DOI: 10.1056/Nejm198908033210512 |
0.45 |
|
| 1989 |
Weiner WJ, Factor SA, Sanchez-Ramos JR. The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 732-5. PMID 2746265 DOI: 10.1136/Jnnp.52.6.732 |
0.566 |
|
| 1989 |
Factor SA, Sanchez-Ramos JR, Weiner WJ, Ingenito AM. Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 83-8. PMID 2709040 DOI: 10.1136/Jnnp.52.1.83 |
0.566 |
|
| 1989 |
Weiner WJ, Singer C. Parkinson's disease and nonpharmacologic treatment programs Journal of the American Geriatrics Society. 37: 359-363. PMID 2646351 DOI: 10.1111/J.1532-5415.1989.Tb05505.X |
0.38 |
|
| 1989 |
Singer C, Weiner WJ, Sanchez-Ramos JR, Ackerman M. Sexual Dysfunction in Men with Parkinson's Disease Neurorehabilitation and Neural Repair. 3: 199-204. DOI: 10.1177/136140968900300405 |
0.345 |
|
| 1989 |
Factor SA, Weiner WJ. Retrospective evaluation of vitamin E therapy in Parkinson's disease Annals of the New York Academy of Sciences. 570: 441-442. DOI: 10.1111/J.1749-6632.1989.Tb14951.X |
0.554 |
|
| 1988 |
Factor SA, Sanchez-Ramos JR, Weiner WJ. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 529-33. PMID 3288717 DOI: 10.1136/Jnnp.51.4.529 |
0.57 |
|
| 1988 |
Levin BE, Llabre MM, Weiner WJ. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory Journal of Neurology, Neurosurgery and Psychiatry. 51: 1401-1404. PMID 3236018 DOI: 10.1136/Jnnp.51.11.1401 |
0.348 |
|
| 1988 |
Factor SA, Sanchez-Ramos JR, Weiner WJ. Cocaine and Tourette's syndrome. Annals of Neurology. 23: 423-4. PMID 3164176 DOI: 10.1002/Ana.410230431 |
0.456 |
|
| 1988 |
Factor SA, Sanchez-Ramos J, Weiner WJ. Delayed-onset dystonia associated with corticospinal tract dysfunction. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 201-10. PMID 3057351 DOI: 10.1002/Mds.870030304 |
0.491 |
|
| 1988 |
Factor SA, Sanchez-Ramos J, Weiner WJ. Trauma as an etiology of parkinsonism: a historical review of the concept. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 30-6. PMID 3050470 DOI: 10.1002/Mds.870030105 |
0.59 |
|
| 1988 |
Levin BE, Llabre MM, Weiner WJ. Neuropsychological correlates of early Parkinson's disease: evidence for frontal lobe dysfunction Annals of the New York Academy of Sciences. 537: 518-619. DOI: 10.1111/J.1749-6632.1988.Tb42145.X |
0.406 |
|
| 1987 |
Sanchez-Ramos JR, Hefti F, Weiner WJ. Paraquat and Parkinson's disease. Neurology. 37: 728. PMID 3561790 DOI: 10.1212/WNL.37.4.728 |
0.339 |
|
| 1987 |
Weiner WJ, Factor SA, Sanchez-Ramos J, Berger J. A double-blind evaluation of ciladopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 211-7. PMID 3332914 DOI: 10.1002/Mds.870020308 |
0.531 |
|
| 1987 |
Sanchez-Ramos JR, Factor SA, Weiner WJ. Paraquat and Parkinson's disease Neurology. 37: 1820-1820. DOI: 10.1212/WNL.37.11.1820-a |
0.559 |
|
| 1986 |
Hefti F, Weiner WJ. Nerve growth factor and Alzheimer's disease. Annals of Neurology. 20: 275-81. PMID 3532929 DOI: 10.1002/Ana.410200302 |
0.32 |
|
| 1981 |
Weiner WJ, Nausieda PA. Carbidopa-levodopa ratio in Parkinson's disease. Archives of Neurology. 38: 534. PMID 7247796 DOI: 10.1001/archneur.1981.00510080096020 |
0.338 |
|
| 1981 |
Glantz R, Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. The effect of bromocriptine (BCT) on the on-off phenomenon. Journal of Neural Transmission. 52: 41-7. PMID 7026735 DOI: 10.1007/Bf01253095 |
0.359 |
|
| 1980 |
Koller WC, Weiner WJ, Diamond BI, Nausieda PA, Klawans HL. The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent. Neuropharmacology. 19: 831-7. PMID 7191490 DOI: 10.1016/0028-3908(80)90079-9 |
0.344 |
|
| 1979 |
Goetz CG, Weiner WJ. Huntington's disease: Current concepts of therapy Journal of the American Geriatrics Society. 27: 23-26. PMID 153351 DOI: 10.1111/J.1532-5415.1979.Tb01716.X |
0.383 |
|
| 1978 |
Klawans HL, Goetz CG, Volkman P, Nausieda PA, Weiner WJ. Lergotrile in the treatment of parkinsonism. Neurology. 28: 699-702. PMID 566868 DOI: 10.1212/WNL.28.7.699 |
0.322 |
|
| 1978 |
Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders. Advances in Experimental Medicine and Biology. 90: 21-47. PMID 145167 DOI: 10.1007/978-1-4684-2511-6_2 |
0.366 |
|
| 1973 |
Klawans HL, Rubovits R, Patel BC, Weiner WJ. Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior. Journal of the Neurological Sciences. 17: 303-8. PMID 4653965 DOI: 10.1016/0022-510X(72)90035-4 |
0.301 |
|
| 1973 |
Weiner WJ, Klawans HL. Lingual-facial-buccal movements in the elderly. I. Pathophysiology and treatment. Journal of the American Geriatrics Society. 21: 314-7. PMID 4268288 DOI: 10.1111/J.1532-5415.1973.Tb01228.X |
0.323 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Josiah AF, Gruber-Baldini AL, Anderson KE, Fishman PS, Weiner WJ, Reich SG, Shulman LM. The effects of gait impairment with and without freezing of gait in Parkinson's disease. Parkinsonism & Related Disorders. 18: 239-42. PMID 22079524 DOI: 10.1016/J.Parkreldis.2011.10.008 |
0.299 |
|
| 2009 |
Holloway R, Marek K, Biglan K, Dick A, Fahn S, Julian-Baros E, Kamp C, Kieburtz K, Lang A, McDermott M, Seibyl J, Shinaman A, Shoulson I, Weiner W. Long-term effect of initiating Pramipexole vs Levodopa in early Parkinson disease Archives of Neurology. 66: 563-570. PMID 19433655 DOI: 10.1001/archneurol.2009.32 |
0.299 |
|
| 2005 |
Weiner WJ. Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada. Reviews in Neurological Diseases. 2: 27-9. PMID 16400301 |
0.297 |
|
| 1979 |
Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Clinical and experimental studies of phenytoin-induced hyperkinesias. Journal of Neural Transmission. 45: 291-305. PMID 490152 DOI: 10.1007/Bf01247146 |
0.293 |
|
| 2008 |
Weiner WJ. Parkinson's disease and movement disorders. Reviews in Neurological Diseases. 5: 86-9. PMID 18660741 |
0.293 |
|
| 2006 |
Haines S, Chen H, Anderson KE, Fishman PS, Shulman LM, Weiner WJ, Reich SG. When do patients with Parkinson disease disclose their diagnosis? Neurology. 67: 488-90. PMID 16894111 DOI: 10.1212/01.Wnl.0000228223.39519.42 |
0.292 |
|
| 1989 |
Singer C, Sanchez-Ramos J, Weiner WJ. A case of post-traumatic tic disorder Movement Disorders. 4: 342-344. PMID 2682216 DOI: 10.1002/Mds.870040409 |
0.291 |
|
| 2012 |
Lewitt PA, Hauser RA, Lu M, Nicholas AP, Weiner W, Coppard N, Leinonen M, Savola JM. Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study). Neurology. 79: 163-9. PMID 22744665 DOI: 10.1212/WNL.0b013e31825f0451 |
0.289 |
|
| 2008 |
Tanji H, Gruber-Baldini AL, Anderson KE, Pretzer-Aboff I, Reich SG, Fishman PS, Weiner WJ, Shulman LM. A comparative study of physical performance measures in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1897-905. PMID 18709681 DOI: 10.1002/Mds.22266 |
0.289 |
|
| 1982 |
Weiner WJ, Nausieda PA. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease. Archives of Neurology. 39: 451-2. PMID 7103786 DOI: 10.1001/archneur.1982.00510190069027 |
0.289 |
|
| 1982 |
Weiner WJ, Nausieda PA. Meige??s syndrome during long-term dopaminergic therapy in Parkinson??s disease Journal of Clinical Psychopharmacology. 2: 431. DOI: 10.1097/00004714-198212000-00029 |
0.289 |
|
| 2000 |
Landy HJ, Weiner WJ, Calancie B, Harris W, Shulman LM, Singer C, Abrams L, Bowen B. Electromyography during stereotactic pallidotomy for Parkinson's disease. Stereotactic and Functional Neurosurgery. 74: 21-9. PMID 11124661 DOI: 10.1159/000056459 |
0.287 |
|
| 2008 |
Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, Weiner WJ. The evolution of disability in Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 790-6. PMID 18361474 DOI: 10.1002/Mds.21879 |
0.286 |
|
| 1994 |
Jankovic J, Shoulson I, Weiner WJ. Early-stage Parkinson's disease: to treat or not to treat Neurology. 44: S4-7. PMID 8121578 |
0.284 |
|
| 2002 |
Anderson KE, Weiner WJ. Psychiatric symptoms in Parkinson's disease. Current Neurology and Neuroscience Reports. 2: 303-9. PMID 12044249 |
0.283 |
|
| 2010 |
Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the unified Parkinson's disease rating scale. Archives of Neurology. 67: 64-70. PMID 20065131 DOI: 10.1001/Archneurol.2009.295 |
0.281 |
|
| 2008 |
McDade E, Weiner WJ, Shulman LM. Metatarsal fracture as a consequence of foot dystonia in Parkinson's disease. Parkinsonism & Related Disorders. 14: 353-5. PMID 18457984 DOI: 10.1016/j.parkreldis.2007.07.005 |
0.281 |
|
| 1999 |
Weiner WJ, Shulman LM, Oertel WH. Do we need more drugs to treat Parkinson's disease? Advances in Neurology. 80: 481-3. PMID 10410759 |
0.28 |
|
| 2012 |
Figari-Jordan R, Gruber-Baldini A, Anderson K, Reich S, Weiner W, Fishman P, Shulman L. Comparison of Disability and Quality of Life in Parkinsonian Syndromes (P06.067) Neurology. 78: P06.067-P06.067. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.067 |
0.279 |
|
| 2004 |
Weiner WJ. Initial treatment of Parkinson disease: levodopa or dopamine agonists. Archives of Neurology. 61: 1966-9. PMID 15596623 DOI: 10.1001/archneur.61.12.1966 |
0.277 |
|
| 1978 |
Weiner WJ, Goetz C, Nausleda PA, Klawans HL. Clonazepam and dopamine-related stereotyped behavior. Life Sciences. 21: 901-6. PMID 562960 DOI: 10.1016/0024-3205(77)90253-3 |
0.275 |
|
| 1973 |
Weiner WJ, Klawans HL. Lingual-facial-buccal movements in the elderly. II. Parthogenesis and relationship to senile chorea. Journal of the American Geriatrics Society. 21: 318-20. PMID 4713287 DOI: 10.1111/J.1532-5415.1973.Tb01229.X |
0.275 |
|
| 1998 |
Singer C, Schatz NJ, Bowen B, Eidelberg D, Kazumata K, Sternau L, Shulman LM, Weiner WJ. Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 135-9. PMID 9452338 DOI: 10.1002/Mds.870130125 |
0.272 |
|
| 2010 |
Hawley JS, Robottom BJ, Weiner WJ. Multiple system atrophy. Reviews in Neurological Diseases. 7: e45-55. PMID 20944523 DOI: 10.3909/rind0247 |
0.272 |
|
| 2008 |
Tanji H, Anderson KE, Gruber-Baldini AL, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Mutuality of the marital relationship in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1843-9. PMID 18759355 DOI: 10.1002/Mds.22089 |
0.271 |
|
| 2007 |
Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, ... ... Weiner WJ, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E |
0.27 |
|
| 2011 |
Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Racial and socioeconomic disparities in parkinsonism. Archives of Neurology. 68: 498-503. PMID 21149802 DOI: 10.1001/Archneurol.2010.326 |
0.267 |
|
| 2012 |
Perry C, Holmes K, Anderson K, Gruber-Baldini A, Fishman P, Shulman L, Weiner W, Reich S. Are Patients with Psychogenic Movement Disorders More Likely To Be Healthcare Workers? (P04.033) Neurology. 78: P04.033-P04.033. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.033 |
0.266 |
|
| 1994 |
Gordon MF, Weiner WJ, Koller WC, Rao TH, Chehebar V, Dickson DW. Case 2, 1994: Parkinsonism and cognitive impairment Movement Disorders. 9: 679-686. PMID 7845411 DOI: 10.1002/Mds.870090616 |
0.266 |
|
| 1974 |
Weiner WJ, Goetz C, Westheimer R, Klawans HL. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior. Journal of the Neurological Sciences. 20: 373-9. PMID 4359068 DOI: 10.1016/0022-510X(73)90171-8 |
0.265 |
|
| 2003 |
Shulman JM, Shulman LM, Weiner WJ, Feany MB. From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease. Current Opinion in Neurology. 16: 443-9. PMID 12869801 DOI: 10.1097/01.Wco.0000084220.82329.60 |
0.262 |
|
| 2011 |
Reich SG, Weiner WJ. Group visits for Parkinson disease: "the doctor will see all of you now". Neurology. 76: 1538-9. PMID 21525428 DOI: 10.1212/Wnl.0B013E3182190F85 |
0.261 |
|
| 1980 |
Nausieda PA, Weiner WJ, Klawans HL. Dystonic foot response of Parkinsonism. Archives of Neurology. 37: 132-6. PMID 7356417 DOI: 10.1001/archneur.1980.00500520030003 |
0.26 |
|
| 1979 |
Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Modification of postsynaptic dopaminergic sensitivity by female sex hormones. Life Sciences. 25: 521-6. PMID 573836 DOI: 10.1016/0024-3205(79)90564-2 |
0.26 |
|
| 1978 |
Hitri A, Weiner WJ, Borison RL, Diamond BI, Nausieda PA, Klawans HL. Dopamine binding following prolonged haloperidol pretreatment. Annals of Neurology. 3: 134-40. PMID 655662 DOI: 10.1002/Ana.410030208 |
0.259 |
|
| 2000 |
Weiner WJ. Placebo surgery in trials of therapy for Parkinson's disease. The New England Journal of Medicine. 342: 353; author reply 35. PMID 10660396 |
0.259 |
|
| 2010 |
Hawley J, Robottom B, Reich S, Shulman L, Anderson K, Fishman P, Weiner W. 232 IS GAIT INSTABILITY AND INTELLECTUAL IMPAIRMENT RARE IN EARLY CORTICOBASAL DEGENERATION? Parkinsonism & Related Disorders. 16: S66. DOI: 10.1016/S1353-8020(10)70233-9 |
0.258 |
|
| 2000 |
Weiner WJ. Is levodopa toxic? Archives of Neurology. 57: 408-10. PMID 10714671 DOI: 10.1001/Archneur.57.3.408 |
0.255 |
|
| 1989 |
Levin BE, Llabre MM, Weiner WJ. Cognition in Parkinson's disease Neurology. 39: 1411-1411. DOI: 10.1212/Wnl.39.10.1411-B |
0.25 |
|
| 2012 |
Robottom BJ, Gruber-Baldini AL, Anderson KE, Reich SG, Fishman PS, Weiner WJ, Shulman LM. What determines resilience in patients with Parkinson's disease? Parkinsonism & Related Disorders. 18: 174-7. PMID 21975263 DOI: 10.1016/J.Parkreldis.2011.09.021 |
0.248 |
|
| 1996 |
Shulman LM, David NJ, Weiner WJ. Reply from the Authors: Niemann-Pick; type C Neurology. 46: 1786-1786. DOI: 10.1212/Wnl.46.6.1786 |
0.247 |
|
| 1976 |
Klawans HL, Weiner WJ. The pharmacology of choreatic movement disorders. Progress in Neurobiology. 6: 49-80. PMID 132681 DOI: 10.1016/0301-0082(76)90006-X |
0.244 |
|
| 1986 |
Sanchez-Ramos J, Barrett JN, Goldstein M, Weiner WJ, Hefti F. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons. Neuroscience Letters. 72: 215-20. PMID 2880321 DOI: 10.1016/0304-3940(86)90083-2 |
0.243 |
|
| 1993 |
Singer C, Berger JR, Bowen BC, Bruce JH, Weiner WJ. Akinetic-rigid syndrome in a 13-Year-Old girl with HIV-Related progressive multifocal leukoencephalopathy Movement Disorders. 8: 113-116. PMID 8419794 DOI: 10.1002/Mds.870080120 |
0.24 |
|
| 2001 |
Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 507-10. PMID 11391746 DOI: 10.1002/mds.1099 |
0.24 |
|
| 1993 |
Mash DC, Sanchez-Ramos J, Weiner WJ. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice Advances in Neurology. 60: 133-139. PMID 8420130 |
0.238 |
|
| 1998 |
Shulman LM, Gallo BV, Weiner WJ. Acquired abducens-trigeminal synkinesis. Neurology. 50: 1507-8. PMID 9596026 DOI: 10.1212/Wnl.50.5.1507 |
0.238 |
|
| 1989 |
Weiner WJ, Singer C, Sanchez-Ramos J. Progression of parkinson’s disease Neurology. 39: 1139. PMID 2761717 DOI: 10.1212/Wnl.39.8.1139 |
0.238 |
|
| 1980 |
Koller WC, Weiner WJ, Klawans HL, Nausieda PA. Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity. Neuropharmacology. 19: 387-91. PMID 6104309 DOI: 10.1016/0028-3908(80)90191-4 |
0.238 |
|
| 1995 |
Shulman LM, Lang AE, Jankovic J, David NJ, Weiner WJ. Case 1, 1995: psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 257-62. PMID 7651440 DOI: 10.1002/Mds.870100304 |
0.237 |
|
| 2008 |
Weiner WJ, Reich SG. Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough. Neurology. 71: 470-1. PMID 18695156 DOI: 10.1212/01.Wnl.0000324860.70391.25 |
0.234 |
|
| 1992 |
Sanchez-Ramos JR, Song S, Mash DC, Weiner WJ. 21-Aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity Journal of Neurochemistry. 58: 328-334. PMID 1727440 DOI: 10.1111/J.1471-4159.1992.Tb09314.X |
0.234 |
|
| 1996 |
Gallo BV, Shulman LM, Weiner WJ, Petito CK, Berger JR. HIV encephalitis presenting with severe generalized chorea. Neurology. 46: 1163-5. PMID 8780114 DOI: 10.1212/Wnl.46.4.1163 |
0.231 |
|
| 1981 |
Weiner WJ, Koller WC, Perlik S, Nausieda PA, Klawans HL. Drug holiday and management of Parkinson disease. Neurology. 30: 1257-61. PMID 7192805 DOI: 10.1212/WNL.30.12.1257 |
0.231 |
|
| 2014 |
Salazar-Montero R, Kassubek J, Weiner WJ. Non-Parkinson’s disease tremor Imaging Acute Neurologic Disease: a Symptom-Based Approach. 301-316. DOI: 10.1017/CBO9781139565653.020 |
0.231 |
|
| 1992 |
Sanchez-Ramos JR, Song S, Oppenheimer J, Mash D, Weiner WJ. Analysis of the protective effects of 21-aminosteroids in MPP+-induced neurotoxicity to dopaminergic neurons in mesencephalic cultures Annals of the New York Academy of Sciences. 648: 338-339. PMID 1637065 DOI: 10.1111/J.1749-6632.1992.Tb24574.X |
0.23 |
|
| 1988 |
Sanchez-Ramos JR, Michel P, Weiner WJ, Hefti F. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence. Journal of Neurochemistry. 50: 1934-44. PMID 2897430 DOI: 10.1111/J.1471-4159.1988.Tb02500.X |
0.23 |
|
| 1989 |
Koller W, Lang A, Vetere-Overfield B, Findley L, Cleeves L, Factor S, Singer C, Weiner W. Psychogenic tremors. Neurology. 39: 1094-9. PMID 2761704 DOI: 10.1212/WNL.39.8.1094 |
0.229 |
|
| 1983 |
Weiner WJ, Luby ED. Persistent akathisia following neuroleptic withdrawal. Annals of Neurology. 13: 466-7. PMID 6838181 DOI: 10.1002/Ana.410130420 |
0.229 |
|
| 2007 |
Anderson KE, Gruber-Baldini AL, Vaughan CG, Reich SG, Fishman PS, Weiner WJ, Shulman LM. Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2204-9. PMID 17876850 DOI: 10.1002/Mds.21687 |
0.225 |
|
| 1977 |
Weiner WJ, Nausieda PA, Klawans HL. Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper. Life Sciences. 20: 1181-5. PMID 850470 DOI: 10.1016/0024-3205(77)90490-8 |
0.225 |
|
| 1991 |
Singer C, Weiner WJ. Re: Clinical significance of ultrastructural findings in the corpora cavernosa of normal and impotent men [6] Journal of Urology. 146: 1379-1380. PMID 1942302 DOI: 10.1016/S0022-5347(17)38111-9 |
0.224 |
|
| 2006 |
Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, Shulman LM, Gronseth G, Weiner WJ. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 996-1002. PMID 16606910 DOI: 10.1212/01.Wnl.0000215428.46057.3D |
0.224 |
|
| 1978 |
Weiner WJ, Goetz C, Nausieda PA, Klawans HL. Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy. European Journal of Pharmacology. 46: 21-4. PMID 303572 DOI: 10.1016/0014-2999(77)90139-X |
0.219 |
|
| 2002 |
Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism & Related Disorders. 8: 193-7. PMID 12039431 DOI: 10.1016/S1353-8020(01)00015-3 |
0.219 |
|
| 1974 |
Klawans HL, Weiner WJ. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias. Journal of Neurology, Neurosurgery, and Psychiatry. 37: 427-30. PMID 4838914 DOI: 10.1136/jnnp.37.4.427 |
0.218 |
|
| 1979 |
Nausieda PA, Weiner WJ, Kanapa DJ, Klawans HL. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism. Neurology. 28: 1183-8. PMID 568738 DOI: 10.1212/WNL.28.11.1183 |
0.217 |
|
| 1999 |
Safirstein B, Shulman LM, Weiner WJ. Successful treatment of hemichorea with olanzapine. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 532-3. PMID 10348489 DOI: 10.1002/1531-8257(199905)14:3<532::Aid-Mds1031>3.0.Co;2-3 |
0.216 |
|
| 2006 |
Adair JC, Rudnicki SA, Boudreau E, Weiner WJ, Coyle PK, Corboy JR. Survey of training programs' means for promoting neurology and attracting trainees. Neurology. 67: 936-9. PMID 17000957 DOI: 10.1212/01.Wnl.0000237324.47522.24 |
0.215 |
|
| 1995 |
Singer C, Weiner WJ. Primary Dystonias: Current Therapeutic Recommendations Cns Drugs. 3: 186-193. DOI: 10.2165/00023210-199503030-00004 |
0.214 |
|
| 2007 |
Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Appendix C: Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 170-176. |
0.214 |
|
| 1990 |
Mash DC, Pablo J, Flynn DD, Efange SMN, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain Journal of Neurochemistry. 55: 1972-1979. PMID 2230804 DOI: 10.1111/J.1471-4159.1990.Tb05784.X |
0.214 |
|
| 1986 |
Hefti F, Hartikka J, Salvatierra A, Weiner WJ, Mash DC. Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neuroscience Letters. 69: 37-41. PMID 3018635 DOI: 10.1016/0304-3940(86)90410-6 |
0.214 |
|
| 2007 |
Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Appendix A: Practice parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommitte of the American Academy Neurology Continuum Lifelong Learning in Neurology. 13: 158-165. |
0.213 |
|
| 2006 |
Shulman LM, Pretzer-Aboff I, Anderson KE, Stevenson R, Vaughan CG, Gruber-Baldini AL, Reich SG, Weiner WJ. Subjective report versus objective measurement of activities of daily living in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 794-9. PMID 16482533 DOI: 10.1002/Mds.20803 |
0.212 |
|
| 2012 |
Puschmann A, Bhidayasiri R, Weiner WJ. Synucleinopathies from bench to bedside. Parkinsonism & Related Disorders. 18: S24-7. PMID 22166445 DOI: 10.1016/S1353-8020(11)70010-4 |
0.212 |
|
| 2012 |
Figari-Jordan R, Anderson K, Gruber-Baldini A, Reich S, Weiner W, Fishman P, Shulman L. Comparison of Quality of Life and Disability in Three Different Dementias (P07.180) Neurology. 78: P07.180-P07.180. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.180 |
0.211 |
|
| 1980 |
Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Chorea induced by oral contraceptives. Neurology. 29: 1605-9. PMID 574224 DOI: 10.1212/WNL.29.12.1605 |
0.209 |
|
| 1994 |
Singer C, Green BA, Bruce JH, Bowen BC, Weiner WJ. Late presentation of congenital muscular torticollis: Use of MR imaging and CT scan in diagnosis Movement Disorders. 9: 100-103. PMID 8139587 DOI: 10.1002/Mds.870090117 |
0.208 |
|
| 1995 |
Shulman LM, Singer C, Weiner WJ. Risperidone in gilles de la tourette syndrome Neurology. 45: 1419. PMID 7542376 DOI: 10.1212/Wnl.45.7.1419 |
0.207 |
|
| 1995 |
Shulman LM, David NJ, Weiner WJ. Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type C. Neurology. 45: 1739-43. PMID 7675237 |
0.206 |
|
| 1982 |
Weiner WJ, Nausieda PA, Glantz RH. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology. 31: 1555-6. PMID 6118844 DOI: 10.1212/WNL.31.12.1555 |
0.204 |
|
| 1982 |
Weiner WJ, Nausieda PA, Klawans HL. Drug holidays in management of Parkinson disease Neurology. 32: 683-683. DOI: 10.1212/WNL.32.6.683-a |
0.2 |
|
| 1982 |
Weiner WJ, Nausieda PA, Klawans HL. Drug holiday and management of Parkinson disease Neurology. 32: 1206-1206. DOI: 10.1212/WNL.32.10.1206 |
0.2 |
|
| 1979 |
Milner-Brown HS, Fisher MA, Weiner WJ. Electrical properties of motor units in Parkinsonism and a possible relationship with bradykinesia. Journal of Neurology, Neurosurgery, and Psychiatry. 42: 35-41. PMID 762583 DOI: 10.1136/jnnp.42.1.35 |
0.197 |
|
| 1993 |
Tomer R, Levin BE, Weiner WJ. Obsessive-compulsive symptoms and motor asymmetries in Parkinson’s disease Neuropsychiatry, Neuropsychology and Behavioral Neurology. 6: 26-30. |
0.196 |
|
| 2002 |
Weiner WJ. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology. 58: 156; author reply 15. PMID 11791587 |
0.194 |
|
| 2010 |
Mitchell A, Anderson K, Medalie J, Gruber-Baldini A, Robottom B, Fishman P, Reich S, Weiner W, Shulman L. Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease? Neurotherapeutics. 7: 141-142. DOI: 10.1016/J.Nurt.2009.09.014 |
0.194 |
|
| 2013 |
Fuller RL, Van Winkle EP, Anderson KE, Gruber-Baldini AL, Hill T, Zampieri C, Weiner WJ, Shulman LM. Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability. Parkinsonism & Related Disorders. 19: 325-8. PMID 23265679 DOI: 10.1016/J.Parkreldis.2012.11.011 |
0.194 |
|
| 1982 |
Weiner WJ, Werner TR. Mania-induced remission of tardive dyskinesia in manic-depressive illness. Annals of Neurology. 12: 229-30. PMID 7125612 DOI: 10.1002/Ana.410120241 |
0.194 |
|
| 1980 |
Nausieda PA, Grossman BJ, Koller WC, Weiner WJ, Klawans HL. Sydenham chorea: an update. Neurology. 30: 331-4. PMID 7189038 DOI: 10.1212/WNL.30.3.331 |
0.19 |
|
| 1996 |
Shulman LM, Singer C, Weiner WJ. Phenytoin-induced focal chorea Movement Disorders : Official Journal of the Movement Disorder Society. 11: 111-114. PMID 8771085 DOI: 10.1002/Mds.870110128 |
0.189 |
|
| 2012 |
Hallett M, Weiner WJ, Kompoliti K. Psychogenic movement disorders. Parkinsonism & Related Disorders. 18: S155-7. PMID 22166419 DOI: 10.1016/S1353-8020(11)70048-7 |
0.188 |
|
| 1982 |
Goetz CG, Weiner WJ, Nausieda PA, Klawans HL. Tardive Dyskinesia Clinical Neuropharmacology. 5: 3-22. DOI: 10.1097/00002826-198205010-00002 |
0.183 |
|
| 1981 |
Tanner C, Goetz CG, Weiner WJ. Anticholinergics and tardive dyskinesia. The American Journal of Psychiatry. 137: 1470-1. PMID 6108080 DOI: 10.1176/ajp.137.11.1470 |
0.18 |
|
| 1981 |
Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sciences. 28: 2173-8. PMID 7195969 DOI: 10.1016/0024-3205(81)90625-1 |
0.178 |
|
| 2007 |
Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, Shulman LM, Gronseth G, Weiner WJ. Appendix F: Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 193-199. |
0.178 |
|
| 2012 |
Hawley JS, Weiner WJ. Hemiballismus: current concepts and review. Parkinsonism & Related Disorders. 18: 125-9. PMID 21930415 DOI: 10.1016/j.parkreldis.2011.08.015 |
0.177 |
|
| 1974 |
Weiner WJ, Klawans HL. Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 36: 747-52. PMID 4753871 DOI: 10.1136/jnnp.36.5.747 |
0.176 |
|
| 2012 |
Puschmann A, Bhidayasiri R, Weiner W. 1.3.1 SYNUCLEINOPATHIES FROM BENCH TO BEDSIDE (PD, MSA, ADHD, RLS) Parkinsonism & Related Disorders. 18: S2-S3. DOI: 10.1016/S1353-8020(11)70082-7 |
0.174 |
|
| 1981 |
Koller WC, Weiner WJ, Perlik S, Nausieda PA, Goetz CG, Klawans HL. Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology. 31: 473-6. PMID 7194441 DOI: 10.1212/WNL.31.4.473 |
0.172 |
|
| 2013 |
Tanji H, Koyama S, Wada M, Kawanami T, Kurita K, Tamiya G, Saito N, Suzuki K, Kato T, Anderson KE, Gruber-Baldini AL, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Comparison of caregiver strain in Parkinson's disease between Yamagata, Japan, and Maryland, The United States. Parkinsonism & Related Disorders. 19: 628-33. PMID 23514630 DOI: 10.1016/J.Parkreldis.2013.02.014 |
0.172 |
|
| 2010 |
Hawley JS, Robottom BJ, Weiner WJ. Essential tremor. Reviews in Neurological Diseases. 7: e69-75. PMID 20944525 DOI: 10.3909/rind0251 |
0.169 |
|
| 2013 |
Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, ... ... Weiner WJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 80: 496-503. PMID 23359374 DOI: 10.1212/Wnl.0B013E31827F0Fd1 |
0.169 |
|
| 2006 |
Weiner WJ. A unique international event-bringing the Parkinson's community together Reviews in Neurological Diseases. 3: 71-73. PMID 16819422 |
0.168 |
|
| 1981 |
Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Pemoline-induced chorea. Neurology. 31: 356-60. PMID 7193830 DOI: 10.1212/WNL.31.3.256 |
0.168 |
|
| 2015 |
Morrow CD, Smentkowski K, Schwartz S, Armstrong MJ, Gruber-Baldini AL, Anderson KE, Reich SG, Weiner WJ, Shulman LM. Does spouse participation influence quality of life reporting in patients with Parkinson's disease? Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 24: 245-9. PMID 24972974 DOI: 10.1007/S11136-014-0744-2 |
0.166 |
|
| 1978 |
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Annals of Internal Medicine. 88: 327-31. PMID 629494 DOI: 10.7326/0003-4819-88-3-327 |
0.165 |
|
| 1976 |
Klawans HL, Moses H, Nausieda PA, Bergen D, Weiner WJ. Treatment and prognosis of hemiballismus. The New England Journal of Medicine. 295: 1348-50. PMID 980081 DOI: 10.1056/NEJM197612092952404 |
0.164 |
|
| 1979 |
Weiner WJ, Nausieda PA, Klawans HL. Methylphenidate-induced chorea: case report and pharmacologic implications. Neurology. 28: 1041-4. PMID 570658 DOI: 10.1212/WNL.28.10.1041 |
0.164 |
|
| 2011 |
Hawley JS, Weiner WJ. Psychogenic dystonia and peripheral trauma. Neurology. 77: 496-502. PMID 21810699 DOI: 10.1212/WNL.0b013e3182287aaf |
0.163 |
|
| 2013 |
Bhidayasiri R, Fahn S, Weiner WJ, Gronseth GS, Sullivan KL, Zesiewicz TA. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 81: 463-9. PMID 23897874 DOI: 10.1212/WNL.0b013e31829d86b6 |
0.161 |
|
| 1973 |
Klawans HL, Rubovits R, Ringel SP, Weiner WJ. Observations on the use of methysergide in Huntington's chorea. Neurology. 22: 929-33. PMID 4343347 DOI: 10.1212/WNL.22.9.929 |
0.154 |
|
| 2005 |
Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB, Ondo WG, Gronseth GS, Weiner WJ. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 64: 2008-20. PMID 15972843 DOI: 10.1212/01.Wnl.0000163769.28552.Cd |
0.154 |
|
| 2010 |
Anderson K, Gruber-Baldini A, Medalie J, Reich S, Fishman P, Robottom B, Weiner W, Shulman L. Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity? Neurotherapeutics. 7: 136-136. DOI: 10.1016/J.Nurt.2009.09.029 |
0.153 |
|
| 2011 |
Robottom BJ, Weiner WJ, Comella CL. Early-onset primary dystonia. Handbook of Clinical Neurology. 100: 465-79. PMID 21496603 DOI: 10.1016/B978-0-444-52014-2.00036-7 |
0.149 |
|
| 2007 |
Skidmore F, Anderson K, Fram D, Weiner W. Psychogenic camptocormia Movement Disorders. 22: 1974-1975. PMID 17712851 DOI: 10.1002/mds.21708 |
0.143 |
|
| 1989 |
Leuin BE, Llabre MM, Weiner WJ. Re: Cognition in parkinson’s disease Neurology. 39: 1411. |
0.142 |
|
| 2006 |
Weiner WJ. Levodopa--toxic or neuroprotective? Nature Clinical Practice. Neurology. 2: 518-9. PMID 16990820 DOI: 10.1038/ncpneuro0293 |
0.142 |
|
| 1984 |
Weiner WJ, Nora LM, Glantz RH. Elderly inpatients: postural reflex impairment. Neurology. 34: 945-7. PMID 6539869 DOI: 10.1212/WNL.34.7.945 |
0.138 |
|
| 1977 |
Boros L, Thomas C, Weiner WJ. Large cerebral vessel disease in sickle cell anaemia. Journal of Neurology, Neurosurgery, and Psychiatry. 39: 1236-9. PMID 1011036 DOI: 10.1136/jnnp.39.12.1236 |
0.137 |
|
| 1994 |
Curless RG, Katz DA, Perryman RA, Ferrer PL, Gelblum J, Weiner WJ. Choreoathetosis after surgery for congenital heart disease The Journal of Pediatrics. 124: 737-739. PMID 8176561 DOI: 10.1016/S0022-3476(05)81365-4 |
0.134 |
|
| 1983 |
Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clinical Neuropharmacology. 5: 183-94. PMID 7139632 DOI: 10.1097/00002826-198205020-00003 |
0.132 |
|
| 1977 |
Klawans HL, D'Amico DJ, Nausieda PA, Weiner WJ. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity Psychopharmacology. 55: 49-52. PMID 414261 DOI: 10.1007/BF00432816 |
0.132 |
|
| 2005 |
Beck H, Shulman LM, Dusaj R, Anderson KE, Weiner WJ. Computer skills in patients with movement disorders. Parkinsonism & Related Disorders. 11: 421-6. PMID 16154795 DOI: 10.1016/j.parkreldis.2005.04.008 |
0.13 |
|
| 2009 |
Weiner WJ. What do clinical trials tell us about treating patients? Parkinsonism & Related Disorders. 15: S34-7. PMID 20083003 DOI: 10.1016/S1353-8020(09)70776-X |
0.13 |
|
| 1979 |
Weiner WJ, Carvey PM, Nausieda PA, Klawans HL. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. 29: 1622-5. PMID 41197 DOI: 10.1212/Wnl.29.12.1622 |
0.125 |
|
| 2009 |
Lang A, Weiner W. O.075 Atypical parkinsonism Parkinsonism & Related Disorders. 15: S19. DOI: 10.1016/S1353-8020(09)70090-2 |
0.125 |
|
| 1978 |
Weiner WJ, Nausieda PA, Klawans HL. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper. Neurology. 28: 734-7. PMID 566875 DOI: 10.1212/WNL.28.7.734 |
0.124 |
|
| 1979 |
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Amphetamine-induced hypersensitivity in guinea pigs. Neurology. 29: 1054-7. PMID 572936 DOI: 10.1212/WNL.29.7.1054 |
0.121 |
|
| 2012 |
Robottom BJ, Shulman LM, Weiner WJ. Drug-induced movement disorders: emergencies and management. Neurologic Clinics. 30: 309-20, x. PMID 22284065 DOI: 10.1016/j.ncl.2011.09.007 |
0.12 |
|
| 1929 |
Kaznelson P, Reimann F, Weiner W. Achylische Chloranämie Klinische Wochenschrift. 8: 1071-1074. DOI: 10.1007/BF01761259 |
0.12 |
|
| 2010 |
Robottom B, Anderson K, Medalie J, Gruber-Baldini A, Fishman P, Reich S, Weiner W, Shulman L. Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease Neurotherapeutics. 7: 141-141. DOI: 10.1016/J.Nurt.2009.09.012 |
0.117 |
|
| 2017 |
Perry CG, Holmes KG, Gruber-Baldini AL, Anderson KE, Shulman LM, Weiner WJ, Reich SG. Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers? Movement Disorders Clinical Practice. 4: 62-67. PMID 30713949 DOI: 10.1002/Mdc3.12351 |
0.116 |
|
| 2002 |
Weiner WJ. Levodopa-induced dyskinesias in normal squirrel monkeys. Annals of Neurology. 51: 531; author reply 53. PMID 11921060 DOI: 10.1002/ana.10138 |
0.116 |
|
| 1996 |
Weiner WJ. Handbook of Dystonia Neurology. 47: 313-314. DOI: 10.1212/WNL.47.1.313-b |
0.115 |
|
| 1977 |
Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Levodopa-Induced dopamine receptor hypersensitivity Annals of Neurology. 2: 125-129. DOI: 10.1002/ana.410020207 |
0.115 |
|
| 2011 |
Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB, Okun MS, Sullivan KL, Weiner WJ. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 77: 1752-5. PMID 22013182 DOI: 10.1212/Wnl.0B013E318236F0Fd |
0.114 |
|
| 1982 |
Nausieda PA, Carvey PM, Weiner WJ. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. European Journal of Pharmacology. 78: 335-43. PMID 6978254 DOI: 10.1016/0014-2999(82)90035-8 |
0.113 |
|
| 1969 |
Weiner W, Harrison W, Klawans H. L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. Life Sciences. 8: 971-6. PMID 5808572 DOI: 10.1016/0024-3205(69)90428-7 |
0.11 |
|
| 2002 |
Minagar A, Sheremata WA, Weiner WJ. Transient movement disorders and multiple sclerosis. Parkinsonism & Related Disorders. 9: 111-3. PMID 12473401 DOI: 10.1016/S1353-8020(02)00009-3 |
0.104 |
|
| 1974 |
Klawans HL, Weiner WJ. The effect of d-amphetamine on choreiform movement disorders. Neurology. 24: 312-8. PMID 4274157 DOI: 10.1212/WNL.24.4.312 |
0.103 |
|
| 2013 |
Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE, Smith BA, Reich SG, Weiner WJ, Macko RF. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. Jama Neurology. 70: 183-90. PMID 23128427 DOI: 10.1001/Jamaneurol.2013.646 |
0.103 |
|
| 1982 |
Weiner WJ, Nausieda PA. Parkinsonian features and progressive supranuclear palsy. Archives of Neurology. 39: 672-3. PMID 7125989 DOI: 10.1001/archneur.1982.00510220070024 |
0.097 |
|
| 1975 |
Weiner WJ, Goetz C, Klawans HL. Serotonergic and Antiserotonergic Influences on Apomorphine‐induced Stereotyped Behaviour Acta Pharmacologica Et Toxicologica. 36: 155-160. PMID 1079682 DOI: 10.1111/j.1600-0773.1975.tb00781.x |
0.096 |
|
| 2000 |
Olanow CW, Schapira AHV, Roth T, Weiner WJ, Hoehn MM, Lledo A, Nash J, Arellano FM, Corrigan M, Arnold G, Rye DB, Bliwise DL, Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: Motor vehicle mishaps in people taking pramipexole and ropinirole [6] (multiple letters) Neurology. 54: 274-277. PMID 10636179 |
0.096 |
|
| 1979 |
NAUSIEDA PA, WEINER WJ, KLAWANS HL. Bromocriptine and dopamine receptor hypersensitivity Neurology. 29: 759-759. DOI: 10.1212/WNL.29.5.759 |
0.095 |
|
| 1981 |
Koller WC, Weiner WJ, Perlik S, Nausieda PA, Goetz CG, Klawans HL. Complications of chronic levodopa therapy: Long-term efficacy Of drug holiday Neurology. 31: 473-476. DOI: 10.1212/WNL.31.4_Part_2.473 |
0.095 |
|
| 2003 |
Shulman LM, Minagar A, Weiner WJ. Reversal of parkinsonism following liver transplantation. Neurology. 60: 519. PMID 12578945 |
0.094 |
|
| 1995 |
Weiner WJ, Shulman LM. To the editor: Post-traumatic movement disorders Neurology. 45: 1950. PMID 7478011 DOI: 10.1212/WNL.45.10.1950-b |
0.094 |
|
| 1995 |
Shulman LM, Weiner WJ. Paroxysmal movement disorders Seminars in Neurology. 15: 188-193. PMID 7481139 |
0.093 |
|
| 2011 |
Weiner WJ, Tolosa E. Hyperkinetic movement disorders. Preface. Handbook of Clinical Neurology. 100: ix. PMID 21496566 DOI: 10.1016/B978-0-444-52014-2.00058-6 |
0.092 |
|
| 2012 |
Hallett M, Weiner W, Kompoliti K. 2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1) Parkinsonism & Related Disorders. 18: S88. DOI: 10.1016/S1353-8020(11)70424-2 |
0.092 |
|
| 2002 |
Minagar A, Rabinstein A, Shulman LM, Weiner WJ. Movement disorders. Advances in Neurology. 90: 213-26. PMID 12068453 |
0.092 |
|
| 2009 |
Weiner WJ. Re: J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology. 72: 199; author reply 19. PMID 19139374 DOI: 10.1212/01.wnl.0000344240.27414.6d |
0.091 |
|
| 2000 |
Weiner WJ. Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole. Neurology. 54: 274-5; author reply . PMID 10636180 |
0.09 |
|
| 1985 |
Stein RW, Papp AC, Weiner WJ, Wu KK. Reduction of serum prostacyclin stability in ischemic stroke. Stroke; a Journal of Cerebral Circulation. 16: 16-8. PMID 3880946 DOI: 10.1161/01.STR.16.1.16 |
0.089 |
|
| 1973 |
Klawans HL, Goetz CH, Weiner WJ. Dopamine receptor site sensitivity in hyperthyroid guinea pigs: a possible model of hyperthyroid chorea. Journal of Neural Transmission. 34: 187-93. PMID 4737273 DOI: 10.1007/BF01367508 |
0.087 |
|
| 2007 |
Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB, Ondo WG, Gronseth GS, Weiner WJ. Appendix H: Practice Parameter: Therapies for essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 202-214. |
0.087 |
|
| 1979 |
Koller WC, Weiner WJ, Nausieda PA, Klawans HL. Bromocriptine: decreased clinical effects at higher dosages. Neurology. 29: 1439-40. PMID 573399 DOI: 10.1212/WNL.29.10.1439 |
0.086 |
|
| 2008 |
Munson AE, Sanchez-Ramos J, Weiner WJ. Movement Disorders and Dopaminomimetic Stimulant Drugs Drug Induced Movement Disorders: Second Edition. 351-370. DOI: 10.1002/9780470753217.ch14 |
0.085 |
|
| 1990 |
Levin BE, Llabre MM, Ansley J, Weiner WJ, Sanchez-Ramos J. Do parkinsonians exhibit visuospatial deficits? Advances in Neurology. 53: 311-315. PMID 2239469 |
0.083 |
|
| 2011 |
Lee MH, Pritchard JM, Weiner WJ. Clinical reasoning: a 44-year-old man with a 3-month history of hiccups. Neurology. 77: e145-8. PMID 22170949 DOI: 10.1212/WNL.0b013e31823d7652 |
0.081 |
|
| 2007 |
Weiner WJ, Reich SG. Upper limb tremor induced by peripheral nerve injury. Neurology. 69: 118; author reply 11. PMID 17606895 DOI: 10.1212/01.Wnl.0000270099.87599.77 |
0.081 |
|
| 1981 |
Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. Practical guidelines for drug holidays in parkinsonian patients. Neurology. 31: 641-2. PMID 7194987 DOI: 10.1212/WNL.31.5.641-b |
0.081 |
|
| 2001 |
Weiner WJ, Rabinstein A, Levin B, Weiner C, Shulman LM. Cocaine-induced persistent dyskinesias. Neurology. 56: 964-5. PMID 11294937 DOI: 10.1212/Wnl.56.7.964 |
0.079 |
|
| 1978 |
Klawans HL, Falk DK, Nausieda PA, Weiner WJ. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology. 28: 1064-6. PMID 284201 DOI: 10.1212/WNL.28.10.1064 |
0.077 |
|
| 2012 |
Weiner WJ. Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study. Neurology. Clinical Practice. 2: 265-266. PMID 30123678 DOI: 10.1212/CPJ.0b013e3182789e04 |
0.075 |
|
| 2012 |
Weiner WJ. Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study Neurology: Clinical Practice. 2: 265. DOI: 10.1212/CPJ.0b013e3182789e04 |
0.075 |
|
| 2008 |
Skidmore F, Weiner WJ, Burke R. Neuroleptic-Induced Tardive Dyskinesia Variants Drug Induced Movement Disorders: Second Edition. 257-284. DOI: 10.1002/9780470753217.ch10 |
0.07 |
|
| 1996 |
Shulman LM, Singer C, Weiner WJ. Improvement of both tardive dystonia and akathisia after botulinum toxin injection Neurology. 46: 844-845. PMID 8618701 |
0.068 |
|
| 1978 |
Nausieda PA, Koller WC, Klawans HL, Weiner WJ. Phenytoin and choreic movements. The New England Journal of Medicine. 298: 1093-4. PMID 643025 DOI: 10.1056/NEJM197805112981923 |
0.067 |
|
| 2011 |
Weiner WJ, Reich SG. Another trial, another hour. The Lancet. Neurology. 10: 201-3. PMID 21315655 DOI: 10.1016/S1474-4422(11)70021-7 |
0.064 |
|
| 1996 |
Weiner WJ, Shulman LM. Worth of neurologists. Neurology. 47: 1108. PMID 8857761 |
0.063 |
|
| 1982 |
WEINER WJ. Abrupt Versus Gradual Withdrawal of Antiparkinsonians American Journal of Psychiatry. 139: 256-a-257. DOI: 10.1176/ajp.139.2.256-a |
0.063 |
|
| 2011 |
Hawley JS, Robottom BJ, Weiner WJ. A tale of two tauopathies. Neurology. 76: S67-8. PMID 21321357 DOI: 10.1212/WNL.0b013e31820d57d9 |
0.062 |
|
| 2013 |
Crum-Bailey JM, Dennison DH, Weiner WJ, Hawley JS. The neurology and corresponding genetics of fragile X disorders: Insights into the genetics of neurodegeneration Future Neurology. 8: 225-235. DOI: 10.2217/fnl.12.92 |
0.061 |
|
| 1979 |
Klawans HL, Weiner WJ, Nausieda PA. The effect of lithium on an animal model of tardive dyskinesia. Progress in Neuro-Psychopharmacology. 1: 53-60. PMID 569341 DOI: 10.1016/0364-7722(77)90027-3 |
0.06 |
|
| 2000 |
Montastruc JL, Weiner WJ. Cortical and brain stem hyperexcitability in a pathologically confirmed case of multiple system atrophy Movement Disorders. 15: 362-363. PMID 10752601 DOI: 10.1002/1531-8257(200003)15:2<362::Aid-Mds1036>3.0.Co;2-C |
0.059 |
|
| 2011 |
Robottom BJ, Weiner WJ. Chorea gravidarum. Handbook of Clinical Neurology. 100: 231-5. PMID 21496582 DOI: 10.1016/B978-0-444-52014-2.00015-X |
0.058 |
|
| 2010 |
Weiner WJ. Gait dysfunction and cognition. Reviews in Neurological Diseases. 7: e82-4. PMID 20944527 |
0.057 |
|
| 1977 |
Weiner WJ, Kanapa DJ, Klawans HL. The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB). Life Sciences. 19: 1371-5. PMID 1033446 DOI: 10.1016/0024-3205(76)90436-7 |
0.057 |
|
| 1981 |
Nausieda PA, Tanner CM, Weiner WJ. Opsoclonic Cerebellopathy: A Paraneoplastic Syndrome Responsive to Thiamine Archives of Neurology. 38: 780-781. PMID 7316846 DOI: 10.1001/archneur.1981.00510120080015 |
0.055 |
|
| 2000 |
Shulman LM, Minagar A, Sharma K, Weiner WJ. Amantadine-induced peripheral neuropathy [2] (multiple letters) Neurology. 55: 456-457. PMID 10932296 DOI: 10.1212/wnl.55.3.456-a |
0.053 |
|
| 2005 |
Reich SG, Weiner WJ, Morgan JC, Sethi K, Lang AE, Oaklander AL. Progression of dystonia in complex regional pain syndrome [1] (multiple letters) Neurology. 64: 2162-2163. PMID 15988823 DOI: 10.1212/Wnl.64.12.2162 |
0.048 |
|
| 1973 |
Klawans HL, Goetz C, Weiner WJ. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Neurology. 23: 1234-40. PMID 4147723 DOI: 10.1212/WNL.23.11.1234 |
0.047 |
|
| 2005 |
Reich SG, Weiner WJ. Progression of dystonia in complex regional pain syndrome. Neurology. 64: 2162-3; author reply. PMID 15985605 |
0.044 |
|
| 2010 |
Weiner WJ. Book Review Neurology. 75: 382-382. DOI: 10.1212/wnl.0b013e3181ea165a |
0.043 |
|
| 2001 |
Weiner WJ. Can peripheral trauma induce dystonia? No! Movement Disorders : Official Journal of the Movement Disorder Society. 16: 13-22. PMID 11215572 DOI: 10.1002/1531-8257(200101)16:1<13::AID-MDS1016>3.0.CO;2-W |
0.039 |
|
| 1980 |
NAUSIEDA PA, KOLLER WC, WEINER WJ, KLAWANS HL. Chorea induced by oral contraceptives Neurology. 30: 1131-1131. DOI: 10.1212/wnl.30.10.1131-a |
0.039 |
|
| 2002 |
Jablecki CK, Andary MT, Floeter MK, Miller RG, Quartly CA, Vennix MJ, Wilson JR, Franklin GM, Zahn CA, Alter M, Ashwal S, Dotson RM, Dubinsky RM, French J, Friday GH, ... ... Weiner W, et al. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: Summary statement Muscle and Nerve. 25: 918-922. PMID 12115985 DOI: 10.1002/mus.10185 |
0.039 |
|
| 2001 |
Minagar A, Weiner WJ. Adolf Kussmaul and his respiratory sign. Journal of Medical Biography. 9: 181-3. PMID 11466520 |
0.039 |
|
| 1993 |
Singer C, Weiner WJ, Lange DJ, Brin MF, Greene P, Lovelace RE, Fahn S. Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes [1] Muscle and Nerve. 16: 677. PMID 8389003 DOI: 10.1002/mus.880160615 |
0.037 |
|
| 2010 |
Robottom BJ, Weiner WJ. Teaching neuroImages: Rest tremor mimicking ventricular tachycardia. Neurology. 75: 2134. PMID 21135391 DOI: 10.1212/WNL.0b013e318200d7e6 |
0.036 |
|
| 1998 |
WEINER W. [Problem of autoimmune hemolytic anemias]. Klinische Wochenschrift. 38: 885-93. PMID 13783920 DOI: 10.1007/BF01477993 |
0.033 |
|
| 1963 |
WEINER W, VOS GH. Serology of Acquired Hemolytic Anemias Blood. 22: 606-613. DOI: 10.1182/blood.V22.5.606.606 |
0.03 |
|
| 1979 |
Koller WC, Weiner WJ, Nausieda PA, Klawans HL. Chapter 8 Clinical Neuropharmacology. 4: 157-174. DOI: 10.1097/00002826-197900040-00009 |
0.029 |
|
| 1978 |
Goetz C, Kramer J, Weiner WJ. Chapter 11 Clinical Neuropharmacology. 3: 185-202. DOI: 10.1097/00002826-197800030-00012 |
0.029 |
|
| 1977 |
Weiner WJ, Bergen D. Chapter 1 Clinical Neuropharmacology. 2: 7-24. DOI: 10.1097/00002826-197700020-00002 |
0.029 |
|
| 1976 |
Weiner WJ. Chapter 5 Clinical Neuropharmacology. 1: 107-136. DOI: 10.1097/00002826-197600010-00007 |
0.029 |
|
| 2011 |
Pargeon K, Anderson K, Weiner WJ. Sexual Dysfunction Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. 296-303. DOI: 10.1002/9781444397970.ch27 |
0.028 |
|
| 2013 |
Gold DR, Nadel RE, Vangelakos CG, Davis MJ, Livingston MY, Heath JE, Reich SG, Gojo I, Morales RE, Weiner WJ. Pearls and oy-sters: the utility of cytology and flow cytometry in the diagnosis of leptomeningeal leukemia. Neurology. 80: e156-9. PMID 23547272 DOI: 10.1212/Wnl.0B013E31828Ab295 |
0.028 |
|
| 1996 |
Singer C, Weiner WJ. Male sexual dysfunction Neurologist. 2: 119-129. |
0.027 |
|
| 2006 |
Hexter D, Weiner WJ. WHAT CAUSED VISUAL LOSS IN A PREGNANT WOMAN? Neurology Today. 6: 4. DOI: 10.1097/00132985-200607040-00003 |
0.025 |
|
| 1991 |
Weiner WJ. To the Editor Neurology. 41: 774-774. DOI: 10.1212/wnl.41.6.774-a |
0.02 |
|
| 2003 |
Harris RD, Nindl G, Balcavage WX, Weiner W, Johnson MT. Use of proteomics methodology to evaluate inflammatory protein expression in tendinitis. Biomedical Sciences Instrumentation. 39: 493-9. PMID 12724941 |
0.02 |
|
| 2007 |
Weiner WJ. Your Questions Answered Neurology Now. 3: 39. DOI: 10.1097/01.NNN.0000267368.51065.37 |
0.012 |
|
| 2006 |
Weiner WJ, Rajput A. Conflicts of interest in expert witnesses: is there a solution? Neurology. 67: 2113-4. PMID 17190928 DOI: 10.1212/01.wnl.0000252253.10224.1f |
0.011 |
|
| 2010 |
Weiner WJ. Flexible residency program. Annals of Neurology. 68: 120; author reply 12. PMID 20583221 DOI: 10.1002/ana.22064 |
0.01 |
|
| 1989 |
Lombard J, Levin IH, Weiner WJ. Arsenic intoxication in a cocaine abuser New England Journal of Medicine. 320: 869. PMID 2927454 |
0.01 |
|
| Hide low-probability matches. |